Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for January 2012
January 3, 2012
- Teva Announces Management Succession
- Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA(TM) (aflibercept) Injection
- Onfi (clobazam) tablets now available in the US at retail pharmacies
- FDA Approves Pneumococcal 13 Vaccine
- Shlomo Yanai to Resign As Teva CEO in May
- Analysts: Yanai Resignation Will Boost Stock Price
- J&J Seeks OK for New Use for Anticlotting Drug
January 4, 2012
- Quintiles Launches Digital Patient Recruitment Unit
- AAIPharma Services Acquires Celsis Analytical Services
- Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy
- FDA to protect important class of antimicrobial drugs for treating human illness
January 5, 2012
- Survey: NJ Pharm Sector Slows
- Promising Results of Novel Combination Vaccine
- Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
- Poniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board Ronald A. Martell Named Chairman of the Board, Steps Down as CEO
- Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb
- Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
- Temporary Halt of Gaster-D 20mg Tablet Exports to Korea
- Eli Lilly 2012 Profit Forecast Misses Expectations
- Morgan Stanley: Teva Raised Copaxone Price 15 Percent
- AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
- Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-One(R) Competitor Product
- FORMA Therapeutics Announces Collaboration with Boehringer Ingelheim to Develop Novel Oncology Drugs
- Healthcare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
- XOMA Streamlines Operations to Invest in Value-Creating Activities
January 6, 2012
- Pfizer Inc.'s 4,220 Layoffs During 2011 are Second Most in Pharmaceutical Industry
- Amarin Hits Bumps in the Road
- Cangene Announces Workforce Reorganization
- FDA Statement on Recently Terminated Clinical Trial With Doribax (Doripenem)
- Merck CEO: This Year Will Be Better Than 2011
- GlaxoSmithKline to Appeal Argentine Vaccine Fines
- Targacept: Alzheimer's Drug Studies Will Continue
- Cangene Cuts 120 Jobs, Shakes Up Management in Efficiency Drive
- Dendreon Jumps As 4Q Provenge Sales Improve
January 9, 2012
- GSK and Theravance Announce Initial Outcomes from Pivotal Phase III Studies for Once-daily Relovair in COPD and Asthma
- NICE Needs More Evidence on New Treatment for People with Common Heart Condition
- Bristol-Myers Squibb to Acquire Inhibitex
- AstraZeneca Reaffirms December 2011 Financial Guidance for 2011 and Mid-term Planning Assumptions for the 2010 to 2014 Period
- Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met XR Tablets
- Bayer HealthCare to Share Lab Space with Start-Up Companies
January 10, 2012
- FORMA Therapeutics Announces an Exclusive Cancer Drug Discovery Alliance Focused on Tumor Metabolism with Janssen Biotech, Inc.
- Shire Acquires US Rights to Resolor (prucalopride)
- Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk
- Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics
- Foundation Medicine Announces Collaboration with Sanofi
- Ventana to Collaborate with Pfizer and CST on Companion Diagnostic to Identify Lung Cancer Patients with ALK Gene Rearrangements
- Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility
- UCSF, Sanofi Collaborate to Find New Diabetes Cures
- Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
- Dako and Amgen to Collaborate in Development of A Companion Diagnostic for An Amgen Investigational Cancer Therapy
- Introducing nutritionpossible.com ? A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health
- Survey of Biomedical Industry CEOs Finds Lack of Investment and Regulatory Environment Threaten Future Growth and Innovation
January 11, 2012
- NantWorks Buys Old Pfizer Plant
- Analyst Gauges Financial Loss From Novartis Recall
- Bristol CEO Sees Fruits of Company Transformation
- GSK Responds to the Recent Court Ruling on the COMPAS Study in Mendoza, Argentina
January 12, 2012
- Sanofi-aventis Lays Off 100 in Montreal
- Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
- Gilead Nears Completion of Pharmasset Deal
- College's Drug Find Triggers Pounds 1.6bn Buy-Out
- Questcor Pharmaceuticals Issues Statement
- First Clinical Trial Site Initiated in CSL Behring Phase II/III Pivotal Study of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin
- Mylan Sued Over Generic Version of Diabetes Drug
- Health Care Spending Has Slow Growth Rate Again in 2010
January 13, 2012
- Novartis to Restructure US Business to Strengthen Competitive Position in Light of Loss of Diovan Patent and Announces Charge for Rasilez/Tekturna
- Nuron Biotech Licenses HibTITER Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
- Otsuka Pharmaceutical and UCB Focus Collaboration in the Area of Central Nervous System (CNS) Disorders
- Novartis to Cut Almost 2,000 US Jobs This Year
- FDA Advisors Who Endorsed Contraceptive Had Industry Ties
- Penn's Cancer Institute Is Suing A Former Top Aide and His Firm in the Theft of Intellectual Property
- Klobuchar Warns Drug Makers Over Tactics That Limit Supplies
January 17, 2012
- Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration
- Drug Companies to Disclose Doctor Payments
- Novo Nordisk Partners with Paula Deen and Sons, Bobby and Jamie Deen, on National Diabetes Initiative
- Janssen Research & Development, LLC Opens JANSSEN LABS at San Diego
- Forest Laboratories, Inc. Reports Fiscal Year Third Quarter 2012 Earnings Per Share of $1.04
- Astex Announces Early Transfer of Epigenetics Project to GSK
- Paula Deen Teams With Novo Nordisk on Diabetes
- Pfizer, Medivation End Drug Development Deal
- Valeant Boosts Bid for ISTA Pharmaceuticals to US$7.50 Per Share From $6.50
- 42 Percent of Online Consumers Think Pharma Companies Should be Involved in Online Health Communities
January 18, 2012
- Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
- IMS Signs Agreement to Divest SDI Medical and Promotional Audits
- Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
- Genzyme Announces European Approval of Framingham Manufacturing Plant
- Columbia Labs Plummets on Negative FDA Review
- Shire Slips As Rivals Production Problems Look Set to Ease
- Novartis Receives Chinese OK for Eye Drug Lucentis
- Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
January 19, 2012
- Sandoz Initiates Two More Phase III Biosimilar Trials, Reinforcing Long-Term Global Leadership Commitment
- Bayer HealthCare Expands in Minnesolta
- Announcement of Basic Agreement Concerning Co-Promotion of Anti-Depressant Paxil CR Tablets
- Paula Deen Pledges Money to Diabetes Association
- Research Chemist at Global Pharmaceutical Company Pleads Guilty to Theft of Trade Secrets
January 23, 2012
- Capstone Therapeutics Announces Operational Update
- Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle
- Boston Scientific Announces Favorable Ruling in Patent Infringement Case
January 24, 2012
- Genzyme Announces FDA Approval of Framingham Manufacturing Plant
- Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results
January 25, 2012
- Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011
- Second City Communications Launches Video Service for Sales Effectiveness ? RealBiz Shorts for Sales ? Using Humor to Help Drive Sales Results
January 26, 2012
- Watson Confirms Court Stays Preliminary Injunction
- Baxter Reports Sales and EPS for Fourth Quarter and Full-Year 2011 in Line with Guidance
- Celgene to Acquire Avila Therapeutics
- Illumina Adopts Stockholder Rights Agreement
- Bristol-Myers Squibb Delivers Solid Fourth Quarter Capping a Year Highlighted by New Product Approvals, Continued Execution of Strategic Transactions and Good Operating Performance
- Astrazeneca & Karolinska Institutet Announce Molecular Imaging Research Agreement
January 30, 2012
- Shionogi Establishes a Developmental Subsidiary in EU
- Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.
- Johnson & Johnson Joins Public and Private Partners in the Largest Coordinated Action to Date to Eliminate or Control Neglected Tropical Diseases
- UBM Canon Pharmaceutical Group Announces Realignment for Future Growth
- Watson Announces New Jersey-Based Global R&D Technology Center
January 31, 2012
- Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance
- Biogen Idec Surpasses $5 Billion in 2011 Annual Revenue
- Lilly Reports Fourth-Quarter and Full-Year 2011 Results
- BioSante Pharmaceuticals Provides Corporate Update
- Drug Costs Will Rise as Much as 7 Percent in Some Settings in 2012
- Updated Status of Daiichi Sankyo Priority Development Projects
- Isotechnika Terminates Existing Agreement with ILJIN
- Orexo?s Drug Discovery Collaboration Terminated and OX-CLI/OX-ESI Projects End
- Roche to Nominate Slate of Independent Directors for Election at Illumina, Inc.'s 2012 Annual Meeting
- Monthly Roundup - January 2012
- Sigma-Aldrich Completes Acquisition of BioReliance
